
Clearbridge Investments Llc decreased its stake in Qualcomm Inc (QCOM) by 1.04% based on its latest 2018Q1 regulatory filing with the SEC. Clearbridge Investments Llc sold 6,625 shares as the company’s stock declined 10.48% with the market. The institutional investor held 629,619 shares of the radio and television broadcasting and communications equipment company at the end of 2018Q1, valued at $34.89M, down from 636,244 at the end of the previous reported quarter. Clearbridge Investments Llc who had been investing in Qualcomm Inc for a number of months, seems to be less bullish one the $86.57B market cap company. The stock increased 0.27% or $0.16 during the last trading session, reaching $58.39. About 8.36 million shares traded. QUALCOMM Incorporated (NASDAQ:QCOM) has risen 2.58% since May 31, 2017 and is uptrending. It has underperformed by 9.99% the S&P500.
Pictet Bank & Trust Ltd decreased its stake in Abbott Labs (ABT) by 15.78% based on its latest 2018Q1 regulatory filing with the SEC. Pictet Bank & Trust Ltd sold 7,550 shares as the company’s stock rose 3.04% while stock markets declined. The institutional investor held 40,300 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $2.42M, down from 47,850 at the end of the previous reported quarter. Pictet Bank & Trust Ltd who had been investing in Abbott Labs for a number of months, seems to be less bullish one the $108.82 billion market cap company. The stock increased 1.26% or $0.77 during the last trading session, reaching $62.07. About 5.95M shares traded. Abbott Laboratories (NYSE:ABT) has risen 41.91% since May 31, 2017 and is uptrending. It has outperformed by 29.34% the S&P500.
Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 107 analyst reports since July 24, 2015 according to SRatingsIntel. The company was maintained on Monday, July 10 by BMO Capital Markets. The stock has “Buy” rating by Guggenheim on Thursday, January 25. Barclays Capital upgraded Abbott Laboratories (NYSE:ABT) rating on Wednesday, October 7. Barclays Capital has “Overweight” rating and $52 target. The rating was downgraded by Goldman Sachs on Friday, November 13 to “Neutral”. Morgan Stanley maintained Abbott Laboratories (NYSE:ABT) rating on Thursday, October 19. Morgan Stanley has “Equal-Weight” rating and $6 target. RBC Capital Markets maintained the stock with “Buy” rating in Thursday, October 19 report. The firm has “Buy” rating given on Wednesday, October 18 by Jefferies. The firm has “Buy” rating by Jefferies given on Wednesday, April 18. Jefferies maintained Abbott Laboratories (NYSE:ABT) on Thursday, August 4 with “Buy” rating. The stock of Abbott Laboratories (NYSE:ABT) earned “Overweight” rating by Morgan Stanley on Thursday, January 25.
Investors sentiment decreased to 0.83 in Q1 2018. Its down 0.08, from 0.91 in 2017Q4. It dropped, as 44 investors sold ABT shares while 606 reduced holdings. 126 funds opened positions while 411 raised stakes. 1.22 billion shares or 0.54% more from 1.22 billion shares in 2017Q4 were reported. Blair William And Il stated it has 866,488 shares or 0.37% of all its holdings. Haverford holds 85,898 shares or 0.1% of its portfolio. Pittenger And Anderson stated it has 67,117 shares. Cap Advsr Limited Limited Liability Corporation stated it has 1,123 shares or 0.02% of all its holdings. Thompson Management has invested 0.27% in Abbott Laboratories (NYSE:ABT). Bennicas & Associates Inc reported 18,193 shares. Sigma Counselors reported 3,448 shares or 0.03% of all its holdings. 40,965 are owned by Boyd Watterson Asset Management Lc Oh. Hanson Mcclain owns 0.01% invested in Abbott Laboratories (NYSE:ABT) for 2,228 shares. Fragasso Gru has 0.07% invested in Abbott Laboratories (NYSE:ABT) for 4,654 shares. Beese Fulmer Mngmt holds 1.19% in Abbott Laboratories (NYSE:ABT) or 90,354 shares. Gateway Investment Advisers Ltd Company, a Ohio-based fund reported 1.02M shares. Moreover, Voya Investment Ltd Liability Com has 0.1% invested in Abbott Laboratories (NYSE:ABT). Dekabank Deutsche Girozentrale holds 0.3% or 733,327 shares in its portfolio. Zwj Counsel Incorporated holds 37,114 shares or 0.2% of its portfolio.
Analysts await Abbott Laboratories (NYSE:ABT) to report earnings on July, 19. They expect $0.71 earnings per share, up 14.52% or $0.09 from last year’s $0.62 per share. ABT’s profit will be $1.24B for 21.86 P/E if the $0.71 EPS becomes a reality. After $0.59 actual earnings per share reported by Abbott Laboratories for the previous quarter, Wall Street now forecasts 20.34% EPS growth.
Another recent and important Abbott Laboratories (NYSE:ABT) news was published by Investorplace.com which published an article titled: “The 7 Best Long-Term Stocks for Risk-Off Investors” on May 29, 2018.
Since December 14, 2017, it had 1 insider buy, and 21 selling transactions for $23.88 million activity. The insider Watkin Jared sold 3,000 shares worth $183,579. MANNING JOSEPH J had sold 1,430 shares worth $84,344 on Wednesday, February 28. Shares for $2.69M were sold by Ford Robert B on Tuesday, January 30. The insider Fussell Stephen R sold $667,804. The insider BIRD ROGER sold 8,262 shares worth $518,450. 459 shares were sold by PEDERSON MICHAEL J, worth $27,213 on Friday, February 16.
Analysts await QUALCOMM Incorporated (NASDAQ:QCOM) to report earnings on July, 18. They expect $0.58 earnings per share, down 17.14% or $0.12 from last year’s $0.7 per share. QCOM’s profit will be $859.92M for 25.17 P/E if the $0.58 EPS becomes a reality. After $0.67 actual earnings per share reported by QUALCOMM Incorporated for the previous quarter, Wall Street now forecasts -13.43% negative EPS growth.
Since January 9, 2018, it had 0 buys, and 8 sales for $7.62 million activity. The insider THOMPSON JAMES H sold 50,126 shares worth $3.14M. $78,989 worth of QUALCOMM Incorporated (NASDAQ:QCOM) was sold by ROGERS ALEXANDER H on Tuesday, February 27. $852,989 worth of QUALCOMM Incorporated (NASDAQ:QCOM) shares were sold by AMON CRISTIANO R. $618,603 worth of QUALCOMM Incorporated (NASDAQ:QCOM) was sold by Rosenberg Donald J on Tuesday, May 8.
Among 37 analysts covering Qualcomm Inc. (NASDAQ:QCOM), 15 have Buy rating, 2 Sell and 20 Hold. Therefore 41% are positive. Qualcomm Inc. had 157 analyst reports since July 23, 2015 according to SRatingsIntel. The rating was maintained by Northland Capital on Thursday, February 1 with “Buy”. The stock of QUALCOMM Incorporated (NASDAQ:QCOM) earned “Hold” rating by Deutsche Bank on Thursday, July 20. The rating was maintained by Canaccord Genuity with “Buy” on Wednesday, November 1. UBS maintained QUALCOMM Incorporated (NASDAQ:QCOM) on Thursday, April 26 with “Neutral” rating. JP Morgan downgraded the stock to “Neutral” rating in Wednesday, December 14 report. The rating was maintained by Topeka Capital Markets with “Hold” on Thursday, July 23. Stifel Nicolaus maintained it with “Hold” rating and $5600 target in Thursday, April 19 report. The rating was maintained by Morgan Stanley on Monday, March 19 with “Underweight”. The stock has “Neutral” rating by Nomura on Monday, January 23. Cowen & Co maintained QUALCOMM Incorporated (NASDAQ:QCOM) on Wednesday, January 31 with “Buy” rating.
Investors sentiment decreased to 0.78 in Q1 2018. Its down 0.05, from 0.83 in 2017Q4. It turned negative, as 104 investors sold QCOM shares while 500 reduced holdings. 100 funds opened positions while 370 raised stakes. 1.11 billion shares or 0.11% less from 1.11 billion shares in 2017Q4 were reported. Gradient Invs Llc invested in 1,028 shares or 0% of the stock. Van Eck Assoc Corporation holds 899,908 shares or 0.25% of its portfolio. Covington Capital accumulated 80,752 shares or 0.29% of the stock. Oak Ridge Invests Ltd has invested 0.07% in QUALCOMM Incorporated (NASDAQ:QCOM). Headinvest Ltd Liability has 52,955 shares. Wheatland Incorporated holds 0.71% or 15,480 shares. Hemenway Trust Communications Limited has 6,856 shares. Sather has invested 2.74% in QUALCOMM Incorporated (NASDAQ:QCOM). Meeder Asset Mngmt reported 12,243 shares. Jpmorgan Chase holds 9.17 million shares. Evergreen Capital Management Limited Liability Corporation owns 10,004 shares. Ftb Advisors has 0.03% invested in QUALCOMM Incorporated (NASDAQ:QCOM) for 4,735 shares. Plante Moran Fincl Advisors Lc accumulated 0.01% or 484 shares. Acg Wealth, a Georgia-based fund reported 7,931 shares. Highlander Capital Management Ltd Llc holds 0.41% or 12,703 shares in its portfolio.
Clearbridge Investments Llc, which manages about $105.97 billion US Long portfolio, upped its stake in Tennant Co (NYSE:TNC) by 19,802 shares to 808,452 shares, valued at $54.73 million in 2018Q1, according to the filing. It also increased its holding in Williams Cos Inc Del (NYSE:WMB) by 97,036 shares in the quarter, for a total of 10.67M shares, and has risen its stake in Telecom Italia S P A New (NYSE:TI).

The post Qualcomm (QCOM) Shareholder Clearbridge Investments Lowered Its Holding by $364,375 as Market Value Declined; Pictet Bank & Trust LTD Has Lowered Its Abbott Labs (ABT) Holding as Stock Price Rose appeared first on Stock Market News | HillCountryTimes | Get it Today.
from
https://www.hillcountrytimes.com/2018/05/31/qualcomm-qcom-shareholder-clearbridge-investments-lowered-its-holding-by-364375-as-market-value-declined-pictet-bank-trust-ltd-has-lowered-its-abbott-labs-abt-holding-as-stock-price-rose/
No comments:
Post a Comment